Latest News & Features
Europe
Today could play a pivotal role in the CRISPR patent landscape in Europe. 16 January 2018
Big Pharma
European IP boutique firm Hoyng Rokh Monegier has announced that Benoît Strowel will succeed Willem Hoyng as managing partner. 16 January 2018
Americas
Biopharmaceutical company MiMedx Group has settled a long-standing patent infringement dispute with the Musculoskeletal Transplant Foundation, Medline Industries and Liventa Bioscience. 15 January 2018
Americas
Healthcare firm Nuvo Pharmaceuticals has announced the acquisition of Resultz from US company Piedmont Pharmaceuticals. 15 January 2018
Americas
The US Department of Commerce (DOC) has said that there are “shortcomings” in China’s IP rights when it comes to the country’s pharmaceutical sector. 15 January 2018
Europe
Regeneron Pharmaceuticals has formed a consortium with five other companies to fund the generation of exome sequence data from 500,000 volunteers in the UK. 12 January 2018
Biotechnology
Israel-based Teva Pharmaceuticals has signed a global licence agreement with Alder BioPharmaceuticals. 11 January 2018
Americas
Allergan and the Native American tribe that acquired Allergan’s patents for Restasis have told the US Court of Appeals for the Federal Circuit that patents covering the dry eye treatment are valid. 11 January 2018
Americas
The US Court of Appeals for the Federal Circuit has confirmed that claims within a patent relating to genetically modified soybeans are invalid due to anticipation and obviousness. 11 January 2018
Big Pharma
Allergan is attempting to remove itself from a series of inter partes reviews focused on dry eye treatment Restasis (cyclosporine ophthalmic emulsion). 10 January 2018